Project Grant R01HL174691
Award Date
8/1/24
Completion Date
7/31/29
Dollars Obligated
$809K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $733,805 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to The Regents of the University of California, San Francisco (UCSF) to conduct a 6-month randomized controlled trial. The objective is to test the efficacy of a virtual coaching and social support intervention to improve physical activity, psychosocial, social cognitive, and clinical outcomes for older adults (age 60+) exiting cardiac...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,970,848 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to The Children's Hospital of Philadelphia (CHOP) to evaluate the efficacy of a digital intervention to increase physical activity and improve physical fitness in youth with Fontan circulation. The project aims to: 1) determine if the digital intervention increases physical activity levels, 2) assess if the intervention leads to improvements in...
This federal Project Grant award of $477,290 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to investigate the underlying behavioral mechanisms that contribute to successful and sustainable increases in daily physical activity for COPD patients participating in a home-based pulmonary rehabilitation program. The research will utilize wearable sensors and daily surveys to determine how patterns of physical...
This $702,964 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports a study to examine the impact of implementation facilitation on improving the reach and delivery of the Exercise is Medicine Greenville (EIMG) program. The EIMG program involves assessing patient physical activity levels, providing exercise prescriptions, and referring patients with chronic diseases to tailored community-based...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $540,798 to The Miriam Hospital to develop an adaptive intervention to help under-resourced cardiac rehabilitation patients maintain improvements in health behaviors after completing Phase II cardiac rehabilitation. The project utilizes a Sequential, Multiple Assignment, Randomized Trial (SMART) design to create a stepped care...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), will provide $198,936 to New York University (NYU) School of Medicine to investigate the impact of restrictive drug coverage policies on heart failure care. The key objectives are to: 1) quantify the effects of restrictive drug coverage policies on provider prescribing, patient adherence, and clinical outcomes for...
This $1,250,934 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research Program (CFDA 93.837) supports research to analyze the systems-level interactions of intrinsic cardiac metabolic and mechanical factors, as well as extrinsic vascular and autonomic factors, that determine exercise capacity and cardiac power output reserve. The research plan utilizes computational modeling to integrate individual-specific data from...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research (CFDA 93.837) program provides $364,879 to The Trustees of the University of Pennsylvania to conduct research on physical activity patterns and their association with clinical outcomes in pulmonary arterial hypertension (PAH). The key objectives of the 5-year project are to: 1) identify determinants of heart rate and daily physical activity patterns in PAH...
This $117,789 Project Grant awarded by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) will support a postdoctoral researcher at the University of Minnesota to investigate the role of resistance exercise in the prevention and treatment of heart failure with preserved ejection fraction (HFpEF). The project aims to: 1) elucidate the independent effects of resistance exercise on HFpEF primary and secondary prevention using data from NHLBI cohort studies,...
This $3,832,469 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research on the peripheral mechanisms contributing to exercise intolerance in patients with heart failure with preserved ejection fraction (HFpEF). The research project aims to: Investigate whether abnormal locomotor skeletal muscle afferent feedback reflexes contribute to the impaired cardiovascular and ventilatory...